missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CPT1B Monoclonal Antibody (OTI2A6), TrueMAB™, OriGene
Description
CPT1B Monoclonal antibody specifically detects CPT1B in Human samples. It is validated for Immunohistochemistry (Paraffin), Western Blot
Specifications
Specifications
| Antigen | CPT1B |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Monoclonal |
| Clone | OTI2A6 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 50% glycerol and 0.02% sodium azide |
| Gene | MRPL44 |
| Gene Accession No. | Q9H9J2 |
| Gene Alias | carnitine O-palmitoyltransferase 1, muscle isoform; carnitine O-palmitoyltransferase 1, muscle isoform; synaptonemal complex central element protein 3; carnitine O-palmitoyltransferase 1B; carnitine O-palmitoyltransferase I, mitochondrial muscle isoform; carnitine O-palmitoyltransferase I, muscle isoform; Carnitine palmitoyltransferase 1 beta, muscle isoform; Carnitine palmitoyltransferase 1, muscle; carnitine palmitoyltransferase 1A like; carnitine palmitoyltransferase 1B; carnitine palmitoyltransferase 1B (muscle); carnitine palmitoyltransferase 1B isoform a; carnitine palmitoyltransferase 1b, muscle; carnitine palmitoyltransferase I; carnitine palmitoyltransferase Ibeta 1; carnitine palmitoyltransferase Ibeta 2; carnitine palmitoyltransferase Ibeta 3; carnitine palmitoyltransferase I-like protein; CPT I; Cpt1; cpt1al; CPT1B; CPT1M; Cpt1-m; CPTI; CPTIB; CPT-IB; CPT-Ibeta 1; CPT-Ibeta 3; CPTI-M; EC 2.3.1.21; FLJ55729; FLJ58750; hypothetical protein LOC449677; KIAA1670; LOW QUALITY PROTEIN: carnitine O-palmitoyltransferase 1, muscle isoform; MCCPT1; MCPT1; M-CPT1; M-cpti; muscle-type carnitine palmitoyltransferase I; zgc:103709 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?